Alarico Ariani1, Simone Parisi2, Giacomo M Guidelli3, Marco Bardelli3, Augusto Bertini4, Enrico Fusaro2. 1. Department of Medicine Internal Medicine and Rheumatology Unit, Azienda Ospedaliero - Universitaria Di Parma, Parma, Italy. 2. Department Rheumatology, Azienda Ospedaliera Cittá Della Salute E Della Scienza Di Torino, Torino, Italy. 3. Department of Medicine, Surgery and Neurosciences, Rheumatology Unit, Siena University Hospital, Siena, Italy. 4. Azienda Unità Sanitaria Locale Di Parma, South-east District, Polo Di Langhirano, Parma, Italy.
Abstract
OBJECTIVES: This study aims to investigate if short-term topical treatment with cetylated fatty acid (CFA) cream reduces the detrimental effects of early and advanced knee osteoarthritis (OA). PATIENTS AND METHODS: The study included 113 patients (32 males, 81 females; median age 70.0 years; 95% CI: 69.0 to 71.4 years) with knee OA diagnosed according to American College of Rheumatology classification criteria. Each patient underwent knee X-rays, followed by a CFA topical treatment (two applications per day for one week). Before and after the treatment, patients completed a Western Ontario and McMaster Universities Osteoarthritis Index questionnaire. All knee X-rays were classified according to Kellgren-Lawrence scale. RESULTS: After one week of treatment, decreased Western Ontario and McMaster Universities Osteoarthritis Index overall scores and sub-scale scores were observed in the whole cohort (p<0.005) and Kellgren-Lawrence scale grade 3 group (p<0.05). In the Kellgren-Lawrence scale grade 2 group, overall Western Ontario and McMaster Universities Osteoarthritis Index scores and pain and functional ability sub-scale scores improved (p<0.05). CONCLUSION: Administration of topical CFA may mitigate most common symptoms in knee OA. Our findings suggest that topical CFA is effective in all knee OA patients with slightly higher evidence for those with advanced disease.
OBJECTIVES: This study aims to investigate if short-term topical treatment with cetylated fatty acid (CFA) cream reduces the detrimental effects of early and advanced knee osteoarthritis (OA). PATIENTS AND METHODS: The study included 113 patients (32 males, 81 females; median age 70.0 years; 95% CI: 69.0 to 71.4 years) with knee OA diagnosed according to American College of Rheumatology classification criteria. Each patient underwent knee X-rays, followed by a CFA topical treatment (two applications per day for one week). Before and after the treatment, patients completed a Western Ontario and McMaster Universities Osteoarthritis Index questionnaire. All knee X-rays were classified according to Kellgren-Lawrence scale. RESULTS: After one week of treatment, decreased Western Ontario and McMaster Universities Osteoarthritis Index overall scores and sub-scale scores were observed in the whole cohort (p<0.005) and Kellgren-Lawrence scale grade 3 group (p<0.05). In the Kellgren-Lawrence scale grade 2 group, overall Western Ontario and McMaster Universities Osteoarthritis Index scores and pain and functional ability sub-scale scores improved (p<0.05). CONCLUSION: Administration of topical CFA may mitigate most common symptoms in knee OA. Our findings suggest that topical CFA is effective in all knee OA patients with slightly higher evidence for those with advanced disease.
Entities:
Keywords:
Cetylated fatty acid; cutaneous drug administration; knee osteoarthritis
Authors: William J Kraemer; Nicholas A Ratamess; Carl M Maresh; Jeffrey A Anderson; Jeff S Volek; David P Tiberio; Michael E Joyce; Barry N Messinger; Duncan N French; Matthew J Sharman; Martyn R Rubin; Ana L Gómez; Ricardo Silvestre; Robert L Hesslink Journal: J Strength Cond Res Date: 2005-05 Impact factor: 3.775
Authors: William J Kraemer; Nicholas A Ratamess; Carl M Maresh; Jeffery A Anderson; David P Tiberio; Michael E Joyce; Barry N Messinger; Duncan N French; Matthew J Sharman; Martyn R Rubin; Ana L Gómez; Jeff S Volek; Ricardo Silvestre; Ricardo Salvestre; Robert L Hesslink Journal: J Strength Cond Res Date: 2005-02 Impact factor: 3.775
Authors: William J Kraemer; Nicholas A Ratamess; Jeffrey M Anderson; Carl M Maresh; David P Tiberio; Michael E Joyce; Barry N Messinger; Duncan N French; Martyn R Rubin; Ana L Gómez; Jeff S Volek; Robert Hesslink Journal: J Rheumatol Date: 2004-04 Impact factor: 4.666
Authors: F Salaffi; G Leardini; B Canesi; A Mannoni; A Fioravanti; R Caporali; G Lapadula; L Punzi Journal: Osteoarthritis Cartilage Date: 2003-08 Impact factor: 6.576
Authors: Louise Murphy; Todd A Schwartz; Charles G Helmick; Jordan B Renner; Gail Tudor; Gary Koch; Anca Dragomir; William D Kalsbeek; Gheorghe Luta; Joanne M Jordan Journal: Arthritis Rheum Date: 2008-09-15